Introduction
============

Type-2 diabetes (T2D) is a complex metabolic disease characterized by elevated blood glucose levels due to a combination of insulin resistance and impaired insulin secretion ([@ref-19]). Western life-style with reduced exercise and unhealthy food-habits result in insulin resistance in target tissues such as in liver, muscle and adipose tissue. To cope with increased metabolic demands, pancreatic beta cells secrete more insulin. Failure to compensate contributes to the development of T2D ([@ref-11]). By regulating various cellular processes within the beta cell, microRNAs (miRNAs) have been suggested to play important roles in rapid compensatory response to changing environments ([@ref-8]; [@ref-10]).

MiRNAs are small non-coding RNAs involved in the regulation of gene expression. They bind to the 3'UTR of the target mRNA leading to mRNA degradation and/or translational repression ([@ref-4]). In diabetes, several miRNAs have been shown to be differentially expressed and have been shown to be involved in important beta cell functions and in maintaining beta cell mass ([@ref-10]; [@ref-18]).

The first miRNA discovered in the pancreatic islet cells was miR-375 ([@ref-17]), which is one of the most highly-enriched miRNAs in the pancreatic islets. Since its discovery, miR-375 has been shown to negatively regulate a plethora of genes involved in pancreatic beta cell function ([@ref-7]) such as in insulin secretion by regulating myotrophin (*Mtpn*) ([@ref-17]) and various voltage-gated sodium channels (SCNs) ([@ref-21]). Knock out of miR-375 in mouse (*375KO*), resulted in hyperglycaemic animals with defective proliferative capacity of endocrine cells leading to decreased beta cell mass ([@ref-18]). Studies on islets of *375KO* mice reveal direct regulation of multiple genes involved in the negative control of cellular growth and proliferation such as the apoptosis-inducing factor, mitochondrion-associated 1 (*Aifm1*) and caveolin1 (*Cav1*) ([@ref-18]).

Another highly-enriched beta cell miRNA is miR-200a, demonstrated to be upregulated in islets of the db/db diabetic mouse model and shown to contribute in regulating pancreatic beta cell survival in T2D ([@ref-5]). There are also a number of miRNAs such as miR-132, miR-212, miR-130a and miR-152 shown to be upregulated in the pancreatic islets of the widely-studied T2D model Goto-Kakizaki rats ([@ref-9]) with active roles in beta cell stimulus-secretion coupling ([@ref-15]; [@ref-16]).

Cell lines are commonly utilized to unravel the molecular mechanisms by which miRNAs participate in cellular processes. The ease of handling, maintenance and availability of cell line models make them indispensable tools in molecular biology investigations. Indeed, studying molecular mechanisms underlying fundamental beta cell processes such as the stimulus-secretion coupling have been made possible by tumour-derived rat insulin-secreting cell lines such as INS-1 ([@ref-3]), and its more recent derivative sub-line, INS-1 832/13 cells ([@ref-12]). Recently, the human beta cell line EndoC-βH1 has also been made available which further enabled deeper investigations of molecular mechanisms governing insulin secretion in humans ([@ref-2]; [@ref-20]).

It has been noticed that the global abundance of miRNAs is generally lower in cell lines than in primary tissues of cancer ([@ref-14]). One hypothesis is that the tight cell--cell contacts in primary tissues contribute to the activation of miRNA biogenesis. Indeed, it was shown that higher cellular density or confluence resulted in higher levels of various miRNAs in HeLa and NIH3T3 cells ([@ref-13]; [@ref-22]). Because many functional assays, e.g., insulin secretion assay, being performed on beta cell lines require optimal culture conditions including cell densities, we therefore set out to investigate whether confluence affects the expression of miR-375 and two of its validated targets in the mouse beta cell, *Aifm1* and *Cav1*, in the rat INS-1 832/13 cells and in the human EndoC-βH1 cells. We also investigated the influence of confluence on the expression levels of miR-200a, miR-130a, miR-152, miR-132 and miR-212.

Materials & Methods
===================

Reagents
--------

All reagents were purchased from Sigma Aldrich (St. Louis, MO, USA) unless otherwise stated.

Cell culture, seeding and imaging
---------------------------------

EndoC-βH1 cells (EndoCells, Paris, France) ([@ref-2]; [@ref-20]) (passages between 76--80) were seeded on 24-well plates coated with Matrigel-fibronectin (100 µg/mL and 2 µg/mL; Sigma-Aldrich, Steinheim, Germany) at the following densities: 390,000 cells/well, 312,000 cells/well, 234,000 cells/well and 78,000 cells/well to reach 100%, 80%, 60% and 20% estimated confluence respectively after 48 h. The cells were maintained in a culture medium containing: DMEM (5.6 mM glucose), 2% BSA fraction V (Roche Diagnostics, Mannheim, Germany), 10 mM nicotinamide (Merck Millipore, Darmstadt, Germany), 50 µM 2-mercaptoethanol, 5.5 µg/mL transferrin, 6.7 ng/mL sodium selenite (Sigma-Aldrich), 100 U/mL penicillin, and 100 µg/mL streptomycin (PAA Laboratories, Pasching, Austria).

Rat insulinoma INS-1 832/13 cells (passages between 50--55) ([@ref-12]) were seeded accordingly: 300,000 cells/well, 240,000 cells/well, 180,000 cells/well and 60,000 cells/well to reach 100%, 80%, 60% and 20% estimated confluence respectively after 48 h. The growth area per well in the 24 well plate is 1.9 cm^2^. Cells were maintained in RPMI 1640 medium containing 11.1 mM glucose (HyClone, UT, USA) as previously described ([@ref-21]). Both cell lines were incubated in a humidified atmosphere with 5% CO~2~ at 37 °C for 48 h. All experiments were performed within culture passages in which the cell lines respond robustly to glucose-stimulated insulin secretion assay.

To measure cell-to-cell contact, 300 uL suspension of EndoC-βH1 cells were seeded on microscope slides with 8 chambered wells (growth area per well: 1.0 cm^2^) (Cat. No. 80827; ibidi Gmbh, Planegg, Germany). The corresponding seeding cell densities for each estimated harvest confluency were as follows: 20% confluence: 41,053 cells/cm^2^; 60% confluence: 123,158 cells/cm^2^; 80% confluence: 1642,10 cells/cm^2^; 100% confluence: 205,263 cells/cm^2^. The seeded cells were imaged at 40× magnification on a Zeiss LSM 510 microscope. Cell-to-cell distances between randomly selected cells were measured (*n* = 40--90) and averaged. See [Fig. S1](#supp-1){ref-type="supplementary-material"} for representative image panels with distance measurements.

RNA extraction, RT-PCR and qPCR
-------------------------------

RNA extraction, RT-PCR for total RNA and stem-loop RT-qPCR for microRNA was performed as previously described ([@ref-21]) using the following TaqMan^®^ miRNA Assays: miR-375 (RT_000564), miR-200a (RT_000502), miR-130a (RT_000454), miR-152 (RT_000475), miR-132 (RT_000457), miR-212 (RT_002551), rat U87 (RT_001712), human RNU44 (RT_001094) and human RNU48 (RT_001006) for generating cDNA. The following primers from TaqMan^®^ Gene Expression and TaqMan^®^ miRNA Assays were used for qPCR: Cav1/CAV1 (Rn00755834_m1/Hs00971716_m1), Aifm1/AIFM1 (Rn00442540_m1/ Hs00377585_m1), miR-375 (TM\_ 000564), miR-200a (TM_000502), miR-130a (TM_00454), miR-152 (TM_000475), miR-132 (TM_000457) and miR-212 (TM_002551) were used for qPCR. Hprt1/HPRT1 (Rn_01527840/4333768F) and Ppia/PPIA (Rn\_ 00690933/4333763F) were used as endogenous controls for mRNA expression, while rat U87 (TM_001712) or human RNU44 (TM_001094) and human RNU48 (TM_001006) were used as endogenous control for miRNA expression. The relative quantities were calculated using the ΔΔ*C*~*t*~ method. The average C~*t*~ values of qPCR assays for each duplicate or triplicate runs are provided in [Table S1](#supp-3){ref-type="supplementary-material"}.

Statistical analysis
--------------------

Differences between groups were tested using one-way ANOVA followed by Tukey's multiple comparison test as implemented in GraphPad Prism 7. Data are presented as mean ± SEM.

Results & Discussion
====================

To find out the influence of cell confluence on the expression of selected miRNAs and targets, we utilized the rat (INS-1 832/13) and human (EndoC-βH1) insulin-secreting cell lines seeded at different cell densities, followed by gene expression measurements ([Fig. 1A](#fig-1){ref-type="fig"}). To quantify the cell-to-cell contact, we also seeded EndoC-βH1 cells in parallel, at different densities corresponding to each confluence harvest point. We measured on average 30 µm between cells in 100% confluent plates, while the lowest 20% confluent plates contained cells with an average of 140 µm cell-to-cell distance ([Fig. 1B](#fig-1){ref-type="fig"} and [Fig. S1](#supp-1){ref-type="supplementary-material"}).

![Experimental design and average cell-to-cell distance at harvest.\
(A) Rat (INS-1832/13) and human (EndoC-βH1) insulin-secreting cell lines were seeded at different cell densities prior to downstream assays as outlined. (B) The average distance between cells at different harvest confluences for EndoC-βH1 cells. Data are presented as mean ± SEM of *N* = 40--90 distance measurements from three independent seedings. (∗∗∗) *p* \< 0.001; one-way ANOVA Tukey's multiple comparison test.](peerj-05-3503-g001){#fig-1}

This study mainly addressed the issue whether confluence affects miR-375 expression, as it is one of the most enriched miRNAs in the pancreatic beta cells influencing diverse molecular processes, from insulin secretion to cellular growth and proliferation ([@ref-7]; [@ref-17]; [@ref-18]; [@ref-21]). The genes *Aifm1* and *Cav1* are among the many genes shown to be directly targeted by miR-375 in mouse beta cells. The negative effect of miR-375 on both the mRNA and protein levels of the two genes has been demonstrated, and in the islets of 375KO mice, increased expression of these targets was also detected at the mRNA level ([@ref-18]). *Aifm1* and *Cav1* are involved in signaling mechanisms that negatively regulate cellular growth and proliferation, hence *375KO* mice were found to have reduced beta cell mass and defective proliferative capacity in the pancreatic endocrine cells ([@ref-18]).

In the rat insulin-secreting cell line, INS-1 832/13, we previously showed the reduction of *Aifm1* and *Cav1* mRNA expression upon miR-375 over-expression delineating the conserved targeting in rodents of these genes by miR-375 ([@ref-21]). In humans, computational predictions show that miR-375 has two non-conserved target sites in the 3'UTR of *AIFM1* mRNA (Target Scan v.7.1 release June 2016) ([@ref-1]), and one target site in the *CAV1* 3'UTR identified by another miRNA target prediction program (RNA22 algorithm implemented at miRWalk 2.0) ([@ref-6]).

In INS-1 832/13 cells, we did not detect any significantly altered expression of neither miR-375 nor its targets among the different confluences ([Figs. 2A](#fig-2){ref-type="fig"}--[2C](#fig-2){ref-type="fig"}). Likewise in the human EndoC-βH1 cells, the expression of miR-375 was similar at all confluences ([Fig. 3D](#fig-3){ref-type="fig"}). Interestingly, we observed slightly decreased expression of *CAV1* mRNA at 60% and 100% confluence compared to the 20% confluence ([Fig. 3F](#fig-3){ref-type="fig"}). Although miR-375 is also predicted to target *CAV1* 3'UTR mRNA, miR-375 expression was not elevated at higher confluences, implying that *CAV1* mRNA is potentially regulated by other factors. These results further underline the impact of species-specific effects of miRNA-mediated regulation in cellular processes.

![Expression of miR-375 and its targets in INS-1 832/13 cells (A--C) or in EndoC-βH1 cells (D--F).\
(A) miR-375 expression at different cell confluence of INS-1 832/13 cells. Expression was normalized to rat *U87*. (B and C) *Aifm1* and *Cav1* expression in INS-1 832/13 cells, respectively. Expression was normalized to *Hprt1* and *Ppia*. (D) Expression of miR-375 at different cell density in EndoC-βH1 cells. Expression was normalized to human *RNU44* and *RNU48*. (E and F) *AIFM1* and *CAV1* expression in EndoC-βH1 cells, respectively. Expression were normalized to *HPRT1* and *PPIA*. For all experiments, data are presented as mean of *N* = 3--4 biological replicates, (∗) *p* \< 0.05 using one-way ANOVA Tukey's multiple comparison test.](peerj-05-3503-g002){#fig-2}

![miR-132 and miR-212 expression in INS-1 832/13 cells (A--B) or in EndoC-βH1 cells (C--D) at different confluences.\
Expression was normalized to rat *U87* or to human *RNU44* and *RNU48*. Data are presented as mean ± SEM of *N* = 3--4 biological replicates. (∗) *p* \< 0.05, (∗∗) *p* \< 0.01, (∗∗∗) *p* \< 0.001; one-way ANOVA Tukey's multiple comparison test.](peerj-05-3503-g003){#fig-3}

Among the other miRNAs included in this study, we observed significantly higher expression levels of miR-132 and miR-212 at higher confluences in INS-1 832/13 cells ([Figs. 3A](#fig-3){ref-type="fig"}--[3B](#fig-3){ref-type="fig"}) but only an increasing trend in the human EndoC-βH1 cells ([Figs. 3C](#fig-3){ref-type="fig"}--[3D](#fig-3){ref-type="fig"}). For miR-200a, miR-130a and miR-152, the expression levels were found not to be influenced by cellular confluence ([Fig. S2](#supp-2){ref-type="supplementary-material"}). However, although not significant, we observed a trend of increasing miRNA expression from 20% to higher confluences in the EndoC-βH1 cells ([Figs. S2D](#supp-3){ref-type="supplementary-material"}--[S2F](#supp-3){ref-type="supplementary-material"}). Overall, the pattern of increased miRNA expression with increasing confluence in this study, supports previous observation of increased activation of miRNA biogenesis and expression at higher cellular densities ([@ref-13]; [@ref-22]).

Conclusion
==========

We found virtually no significant differences in the expression levels of miR-375, *CAV1* mRNA and *AIFM1* mRNA at higher confluences, from 60%--100%, either in the rat or human beta cell lines. Moreover, we did not find significant differences in the expression of the other miRNAs tested in either INS-1 832/13 or EndoC-βH1 cells between 80% and 100% confluence. These results are comforting because most functional assays employing pancreatic beta cell lines utilize these confluence levels to attain consistent results. For instance, to ensure optimal insulin secretion in cultured beta cell lines, insulin-secretion assays are commonly performed when the cell culture confluence is at least 90%.

Although we showed that miR-375, which is one of the most enriched beta cell miRNA was not significantly influenced by confluence level in cultured rat and human beta cell lines, we clearly demonstrated that miR-132 and miR-212 are more dependent on cellular densities, as was shown for some miRNAs in other cells types ([@ref-13]; [@ref-22]). One must therefore be cautious in controlling for cell densities when investigating specific miRNAs in *in vitro* systems.

It has been observed that primary tissues generally exhibit higher global miRNA abundance compared to cell lines in part attributed to tighter, and greater cell-to-cell contact in three-dimensions ([@ref-14]). Nevertheless, it remains to be seen in the pancreatic endocrine cells how the three-dimensional organization of the cells impacts the global miRNA expression and hence, the regulation of various cellular processes.
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###### Representative image panels for each estimated harvest confluence

Representative image panels with distance measurements (white lines) between randomly selected cells for each estimated harvest confluence. Scale bar is 50 μm.
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Click here for additional data file.
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###### Expression of miR-200a, miR-130a and miR-152 in INS-1 832/13 cells (A--C) or in EndoC-βH1 cells (D--F) at different confluences

Expression was normalized to rat *U87* or to human *RNU44* and *RNU48*. Data are presented as mean ±SEM of *N* = 3--4 biological replicates.
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Click here for additional data file.
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###### Average Ct values of qPCR assays

###### 

Click here for additional data file.
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